Conflicts of Interest

Conflicts of Interest

Conflicts of interest, whether financial or non-financial, can arise at the intersection of two fundamental missions: to push the boundaries of knowledge and to transfer that knowledge into something meaningful for the benefit of mankind. There may be, e.g., significant personal financial incentives related to patenting and licensing an invention, or to outside consulting or other interests. Considerations of personal financial gain however must not distort objectivity in research, and we must provide a reasonable expectation that the design, conduct, and reporting of research will be free from bias. Legal Affairs can assist you in identifying, managing, or mitigating any conflicts that could interfere with your Institutional responsibilities.

We are committed to helping you, investigator, researcher, and/or faculty member, comply with the LSUHSCS Conflict of Interest in Research (Chancellor's Memorandum-23)and with Conflicts of Interest law (Public Health Service (PHS) regulations on Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought (42 CFR 50) and Responsible Prospective Contractors (45 CFR 94)).


    Who must disclose pursuant to CM-23, SOP LA 101, and the federal law (42 CFR 50/94):

  • All research personnel, regardless of title or position, who are responsible for the design, conduct, or reporting of research at the Institution, regardless of funding source;
  • Senior leadership of the Institution;
  • Subcontractors from outside entities engaged in LSUHSC-S research (if determined by written contractual agreement); and
  • Any individual indirectly involved in research oversight e.g. including, but not limited to, IRB, IACUC, or COI Committee members.

This procedure does not apply to research personnel when all of the following apply:

  • the services performed do not merit professional recognition or publication privileges;
  • the services are the same provided as those typically performed for non-research purposes; and
  • the institution's employees or agents do not administer any study intervention being tested or evaluated under the protocol.

How to When to Disclose:

  • Annual Disclosure is required at the beginning of each new fiscal year and Updated Disclosures are requried within 30 days of discovery or acquisition.
  • Login to SHIELDS COI Xpress at SHEILDS COI Xpress to complete Annual and Updated Disclosures

Resources and Guidelines:

SOP LA101 COI Management  

FAQs COI NIH (18 Oct 2012)

Federal Register Notice (08/25/2011)

NIH Revised Regulation Slide Show

LA Code of Ethics Info Sheet.pdf

If you have any questions about the COI disclosure process, please email